AZN2 quarters
Position history for
Clark Capital Management Group, Inc.'s holdings in ASTRAZENECA PLC
Yes. Clark Capital Management Group holds 608,068 shares of AZN (AstraZeneca), worth $115.3M, as of its Q2 2026 13F filing. It increased the position by 8,016 shares (+1.3%) from Q1 2026. Clark Capital Management Group has held AZN in every 13F on record since Q1 2026, 2 quarterly filings. AZN is 0.6% of Clark Capital Management Group's reported 13F portfolio.
Current Value
$115.3M
Current Shares
608,068
Total Value Change
-$3M
Total Shares Change
+8,016
Other major holders of AZN: VANGUARD CAPITAL MANAGEMENT LLC, Capital International Investors, NORGES BANK